Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Venture capitalists are hesitant to fund new AI labs ('Neolabs'), even those with superstar talent. The primary concern is that any meaningful breakthrough can be quickly replicated by frontier labs like OpenAI, which possess the scale and distribution to capture the value, leaving the startup with acquisition as its only viable exit.

Related Insights

The investment thesis for new AI research labs isn't solely about building a standalone business. It's a calculated bet that the elite talent will be acquired by a hyperscaler, who views a billion-dollar acquisition as leverage on their multi-billion-dollar compute spend.

Small, independent AI labs ("Neo-labs") are not genuine competitors to frontier players like OpenAI. Instead, they serve as a career interlude for high-profile researchers. These individuals can raise capital, enjoy a secondary liquidity event, and work on passion projects before ultimately being re-absorbed into a major lab.

Venture capitalists find the risk/reward for most new AI labs ('neo labs') unattractive due to high valuations and unclear roadmaps. An investment is only justified for exceptional cases like Discovery Loop, which combines a world-class founding team with a vision for a vast, 'infinite' problem space.

To avoid being crushed by incumbents, AI startups must operate on ideas that are both non-obvious ("different") and difficult to execute ("hard"). If a startup's core idea becomes obvious to the world before it achieves significant scale, larger companies with more resources will inevitably co-opt the market.

The venture capital landscape is experiencing extreme concentration, with a handful of AI labs like OpenAI and Anthropic raising sums that rival half of the entire annual VC deployment. This capital sink into a few mega-private companies is a new phenomenon, unlike previous tech booms.

The trend of high-profile researchers leaving large AI companies to start broad, generalist "NeoLabs" is decelerating. The market is entering a new phase where emerging AI startups are more likely to be in stealth, highly specialized, or intentionally unconventional, rather than directly competing on foundational models.

A VC offers an analogy for competing with AI giants like OpenAI: they are 'Godzilla.' Instead of direct confrontation, startups should 'find an alleyway to hide in.' This means focusing on niche applications or non-software domains where they won't be 'stomped' by inevitable foundation model improvements.

The AI ecosystem has over 75 'NeoLabs' spun out from frontier research labs, and two-thirds are projected to be worth nothing. Early funding was based on talent alone, but the market has shifted to demand a viable business model and a clear path to revenue. For these companies, the "next round's a bitch."

A concerning trend is emerging where talented founders, fearing competition from major AI labs, are choosing to build in smaller, niche markets. This flight to perceived safety may limit the creation of ambitious, market-defining companies and represents a misallocation of top talent.

Investing in startups directly adjacent to OpenAI is risky, as they will inevitably build those features. A smarter strategy is backing "second-order effect" companies applying AI to niche, unsexy industries that are outside the core focus of top AI researchers.